Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.
about
Association of Interferon Gamma +874T/A Polymorphism and Leukemia Risk: A Meta-AnalysisTargeting ATM-deficient CLL through interference with DNA repair pathwaysThe genetics of cancer riskAssociations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociGenome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphomaCurrent understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological updateA genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemiaGenome-wide association study identifies multiple risk loci for chronic lymphocytic leukemiaA multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility lociGenome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLLCommon variation at 3p22.1 and 7p15.3 influences multiple myeloma riskA genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk lociMDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisNonsyndromic cleft lip with or without cleft palate and cancer: Evaluation of a possible common genetic background through the analysis of GWAS dataArray CGH in human leukemia: from somatics to genetics.Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemiaEvidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemiaCharacterizing genetic risk at known prostate cancer susceptibility loci in African AmericansFamilial chronic lymphocytic leukemiaMultiple loci are associated with white blood cell phenotypes.A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.Long intergenic non-coding RNAs (LincRNAs) identified by RNA-seq in breast cancer.Familial predisposition and genetic risk factors for lymphoma.Post-GWAS functional characterization of susceptibility variants for chronic lymphocytic leukemia.Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong KongMedical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectThe functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma riskGenome-wide association studies of cancer.Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X.A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestryInherited predisposition to multiple myeloma.Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.Association of cancer susceptibility variants with risk of multiple primary cancers: The population architecture using genomics and epidemiology study.Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia.DNA methylation levels at chromosome 8q24 in peripheral blood are associated with 8q24 cancer susceptibility lociGenome-wide association study identifies multiple susceptibility loci for multiple myeloma.Chromosome 8q24-Associated Cancers and MYC.The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applicationsLymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation
P2860
Q26750761-F27BCDCE-C770-4AF9-A974-EEFC0B059CF8Q26822592-1201124B-210D-422D-A69E-9F7985501962Q27013910-2F006577-B555-4866-AF93-01173AC9571CQ28083556-3D10FD30-D926-4EF8-A5F1-682E3C31F2C0Q28248768-2625C58A-CCD6-487E-949E-7CF6B62F0A02Q28388876-AA4603D5-E65E-4CAA-87F1-54314D718D14Q28943318-5C32D142-CBBA-4092-A1AF-E273ABC440B1Q28943339-2C49B47F-F5EE-4175-AB61-9118DBA04F36Q28943367-27EFCB15-CD36-4B18-ADF0-26150D344C9EQ28943377-DE2132BD-04D3-431A-89A9-0B35D5E54C78Q28943395-D7A19E9B-08C1-4977-8F46-A785F7DAA815Q28943455-04726F9F-D3A7-4A24-97CC-C64213805B0CQ29248527-607699E4-12D8-409F-B8E9-377A8C9A25EBQ30840070-994F1E9A-EA71-4B93-9F2B-07A0B796C9CAQ31130933-F03124A7-22D5-47F8-9656-47889ACD7663Q33397024-EB88483B-8D93-4F09-AE1D-67F56576CBCEQ33648911-B1B8B524-B651-407F-8E13-E551DBD46C9AQ33776198-D255DC96-691D-4C24-AB49-3D384D80D92AQ33921139-460CAF5D-3C08-43C5-B522-754AB24E2744Q33938058-F2080DFC-F29C-4C6E-982E-A18DE862220DQ33954440-2F248CDC-5173-4E84-8EAE-AA0522127314Q33981307-690E6B2A-60B1-4BEB-A26A-903F974FE9F5Q33988959-E6EF8786-04E2-4325-8DB6-D3AD8CDD24D8Q34044984-2CED4051-BBC4-4BC8-B122-149D1D8E7E3DQ34123783-CECE649D-F133-4ACD-915E-FDE430894917Q34132750-DA111503-876B-4EC2-888C-049728B804D4Q34137880-847F809B-733B-4368-A57D-79EA6A523A88Q34156039-20982B07-02AB-45C4-9F6D-B328758D50B1Q34193988-EE137713-31ED-4B6D-9158-5D845B2A5E00Q34269998-89AC13EC-54BD-4BA6-9F9E-3D96B2C0318DQ34353049-E18183A5-A0A1-414F-B25B-D986D77E45D4Q34362677-6F9C46F7-CDCC-4C75-BF59-F19BEDD32A7CQ34439389-C2213D4D-DC34-4257-8151-A2F0AD160B11Q34457646-34F500D3-C36F-4130-AD49-0D559A888EF4Q34576292-850F50D0-F461-456B-AB32-EACCB1C2B104Q34633158-7B529FFE-C7EF-4620-AA1A-E7BCA919948BQ34677689-94A13A82-0500-48E2-94CE-33C4BBB10994Q34972340-8A4116A4-5095-47FA-A696-7D561B81070CQ35029409-78DA9925-48B5-4265-817F-023D86C3B679Q35036813-A9251DAF-1D8C-40C9-8D4D-E49E4FE17676
P2860
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@en
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@nl
type
label
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@en
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@nl
prefLabel
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@en
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@nl
P2093
P2860
P50
P356
P1433
P1476
Common variants at 2q37.3, 8q2 ...... nic lymphocytic leukemia risk.
@en
P2093
Andrew G Hall
Andrew R Pettitt
Anton Parker
Chris Fegan
Chris Pepper
Clara Ruiz-Ponte
David Oscier
Emilio Montserrat
Geoffrey Summerfield
Graham H Jackson
P2860
P2888
P304
P356
10.1038/NG.510
P407
P50
P577
2010-01-10T00:00:00Z
P6179
1026418435